A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix
Objective. Dipsaci Radix (DR) has been used to treat fracture and osteoporosis. Recent reports have shown that myeloid cells from bone marrow can promote the proliferation of lung cancer. However, the action and mechanism of DR has not been well defined in lung cancer. The aim of the present study w...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/7424061 |
id |
doaj-baec6758109446dab256a194e0ad0b92 |
---|---|
record_format |
Article |
spelling |
doaj-baec6758109446dab256a194e0ad0b922020-11-25T02:25:24ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882020-01-01202010.1155/2020/74240617424061A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci RadixJiayan Wu0Shengkun Hong1Xiankuan Xie2Wangmi Liu3Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200032, ChinaQuzhou People’s Hospital, No. 2 Zhongloudi, Quzhou 324000, ChinaThe Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaThe Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaObjective. Dipsaci Radix (DR) has been used to treat fracture and osteoporosis. Recent reports have shown that myeloid cells from bone marrow can promote the proliferation of lung cancer. However, the action and mechanism of DR has not been well defined in lung cancer. The aim of the present study was to define molecular mechanisms of DR as a potential therapeutic approach to treat lung cancer. Methods. Active compounds of DR with oral bioavailability ≥30% and drug-likeness index ≥0.18 were obtained from the traditional Chinese medicine systems pharmacology database and analysis platform. The potential target genes of the active compounds and bone were identified by PharmMapper and GeneCards, respectively. The compound-target network and protein-protein interaction network were built by Cytoscape software and Search Tool for the Retrieval of Interacting Genes webserver, respectively. GO analysis and pathway enrichment analysis were performed using R software. Results. Our study demonstrated that DR had 6 active compounds, including gentisin, sitosterol, Sylvestroside III, 3,5-Di-O-caffeoylquinic acid, cauloside A, and japonine. There were 254 target genes related to these active compounds as well as to bone. SRC, AKT1, and GRB2 were the top 3 hub genes. Metabolisms and signaling pathways associated with these hub genes were significantly enriched. Conclusions. This study indicated that DR could exhibit the anti-lung cancer effect by affecting multiple targets and multiple pathways. It reflects the traditional Chinese medicine characterized by multicomponents and multitargets. DR could be considered as a candidate for clinical anticancer therapy by regulating bone physiological functions.http://dx.doi.org/10.1155/2020/7424061 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jiayan Wu Shengkun Hong Xiankuan Xie Wangmi Liu |
spellingShingle |
Jiayan Wu Shengkun Hong Xiankuan Xie Wangmi Liu A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix Evidence-Based Complementary and Alternative Medicine |
author_facet |
Jiayan Wu Shengkun Hong Xiankuan Xie Wangmi Liu |
author_sort |
Jiayan Wu |
title |
A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix |
title_short |
A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix |
title_full |
A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix |
title_fullStr |
A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix |
title_full_unstemmed |
A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix |
title_sort |
network pharmacology-based study on the anti-lung cancer effect of dipsaci radix |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2020-01-01 |
description |
Objective. Dipsaci Radix (DR) has been used to treat fracture and osteoporosis. Recent reports have shown that myeloid cells from bone marrow can promote the proliferation of lung cancer. However, the action and mechanism of DR has not been well defined in lung cancer. The aim of the present study was to define molecular mechanisms of DR as a potential therapeutic approach to treat lung cancer. Methods. Active compounds of DR with oral bioavailability ≥30% and drug-likeness index ≥0.18 were obtained from the traditional Chinese medicine systems pharmacology database and analysis platform. The potential target genes of the active compounds and bone were identified by PharmMapper and GeneCards, respectively. The compound-target network and protein-protein interaction network were built by Cytoscape software and Search Tool for the Retrieval of Interacting Genes webserver, respectively. GO analysis and pathway enrichment analysis were performed using R software. Results. Our study demonstrated that DR had 6 active compounds, including gentisin, sitosterol, Sylvestroside III, 3,5-Di-O-caffeoylquinic acid, cauloside A, and japonine. There were 254 target genes related to these active compounds as well as to bone. SRC, AKT1, and GRB2 were the top 3 hub genes. Metabolisms and signaling pathways associated with these hub genes were significantly enriched. Conclusions. This study indicated that DR could exhibit the anti-lung cancer effect by affecting multiple targets and multiple pathways. It reflects the traditional Chinese medicine characterized by multicomponents and multitargets. DR could be considered as a candidate for clinical anticancer therapy by regulating bone physiological functions. |
url |
http://dx.doi.org/10.1155/2020/7424061 |
work_keys_str_mv |
AT jiayanwu anetworkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT shengkunhong anetworkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT xiankuanxie anetworkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT wangmiliu anetworkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT jiayanwu networkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT shengkunhong networkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT xiankuanxie networkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix AT wangmiliu networkpharmacologybasedstudyontheantilungcancereffectofdipsaciradix |
_version_ |
1715490640862642176 |